The relationship between testosterone, metabolic syndrome, and mean carotid intima-media thickness in aging men

References

• Tsujimura A. The relationship between testosterone deficiency and men's health. World J Mens Health 2013;31:126–35
   PubMedGoogle Scholar
• Lunenfeld B, Arver S, Moncada I, et al. How to help the aging male? Current approaches to hypogonadism in primary care. Aging Male 2012;15:187–97
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. Aging 2013;16:143–50
   Google Scholar
• Corona G, Rastrelli G, Vignozzi L, et al. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metabol 2011;25:337–53
   PubMed Web of Science ®Google Scholar
• Wyman RA, Mays ME, McBride PE, Stein JH. Ultrasound-detected carotid plaque as a predictor of cardiovascular events. Vasc Med 2006;11:123–30
   PubMed Web of Science ®Google Scholar
• van den Beld AW, Bots ML, Janssen JA, et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003;157:25–31
   PubMed Web of Science ®Google Scholar
• Makinen J, Jarvisalo MJ, Pollanen P, et al. Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 2005;45:1603–8
   PubMed Web of Science ®Google Scholar
• Soisson V, Brailly-Tabard S, Empana JP, et al. Low plasma testosterone and elevated carotid intima-media thickness: importance of low-grade inflammation in elderly men. Atherosclerosis 2012;223:244–9
   PubMed Web of Science ®Google Scholar
• Tsujimura A, Yamamoto R, Okuda H, et al. Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men. Endocrine J 2012;59:809–15
   Google Scholar
• Muller M, van den Beld AW, Bots ML, et al. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004;109:2074–9
   PubMed Web of Science ®Google Scholar
• Tivesten A, Hulthe J, Wallenfeldt K, et al. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol Metabol 2006;91:4433–7
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Mathiesen E, et al. Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 2006;259:576–82
   PubMed Web of Science ®Google Scholar
• Dorr M, Wallaschofski H, Friedrich N. Association of low total testosterone levels and prevalent carotid plaques: result of the study of health in Pomerania. Eur J Epidemiol 2009;24:389–91
   PubMedGoogle Scholar
• Vikan T, Johnsen SH, Schirmer H, et al. Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur J Epidemiol 2009;24:289–95
   PubMed Web of Science ®Google Scholar
• Mathiesen EB, Johnsen SH, Wilsgaard T, et al. Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromso Study. Stroke 2011;42:972–8
   PubMed Web of Science ®Google Scholar
• Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metabol 2005;90:1502–10
   PubMed Web of Science ®Google Scholar
• Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM. Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. J Urol 2012;187:1369–73
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52
   PubMed Web of Science ®Google Scholar
• Malkin CJ, Pugh PJ, Jones RD, et al. Testosterone as a protective factor against atherosclerosis–immunomodulation and influence upon plaque development and stability. J Endocrinol 2003;178:373–80
   PubMed Web of Science ®Google Scholar
• Benten WP, Lieberherr M, Giese G, et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J 1999;13:123–33
   PubMed Web of Science ®Google Scholar
• Benten WP, Lieberherr M, Stamm O, et al. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 1999;10:3113–23
   PubMed Web of Science ®Google Scholar
• Yesilova Z, Ozata M, Kocar IH, et al. The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2000;85:66–70
   Google Scholar
• Fan AZ. Metabolic syndrome and progression of atherosclerosis among middle-aged US adults. J Antheroscler Thromb 2006; 13:46–54
   Google Scholar
• Iglseder B, Cip P, Malaimare L, et al. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005;36:1212–17
   PubMed Web of Science ®Google Scholar
• Adolphe A, Cook LS, Huang X. A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants. Mayo Clinic Proc 2009;84:221–8
   PubMed Web of Science ®Google Scholar
• Lee YH, Shin MH, Kweon SS, et al. Normative and mean carotid intima-media thickness values according to metabolic syndrome in Koreans: the Namwon study. Atherosclerosis 2014;234:230–6
   PubMed Web of Science ®Google Scholar
• Yao L, Herlea-Pana O, Heuser-Baker J, et al. Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease. J Immunol Res 2012;2014:181450
   Google Scholar
• Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol 2013;217:R25–45
   PubMed Web of Science ®Google Scholar
• Corona G, Monami M, Rastrelli G, et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011;8:272–83
   PubMed Web of Science ®Google Scholar
• Filippi S, Vignozzi L, Morelli A, et al. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med 2009;6:3274–88
   PubMed Web of Science ®Google Scholar